Navigation Links
GeoVax Labs, Inc. Moving Operations to Smyrna, Georgia
Date:10/20/2009

ATLANTA, Oct. 20 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) ("GeoVax" or the "Company"), an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced that it will move its corporate headquarters and laboratory operations from the Briarcliff campus of Emory University to Smyrna, Georgia, a northwest suburb of Atlanta, effective November 3, 2009.

The Company has been housed in the Emtech Bio incubator facility (a partnership between Emory University and Georgia Institute of Technology) since its formation in 2001. The new location at 1900 Lake Park Drive, Suite 380, Smyrna, Georgia 30080, will encompass over 8400 square feet of office and laboratory space. The Company will occupy this new headquarters under a 62-month lease. The facility is situated within an existing biotech building in a controlled-access campus, and will house all of the Company's U.S. research and development, process engineering, quality control, regulatory and administrative operations.

Bob McNally, Ph.D., GeoVax's President and Chief Executive Officer stated, "This move will give GeoVax much-needed additional space for our current activities, as well as providing space to accommodate the addition of several new employees to our research and development staff and the resulting expansion of our operations. The new facility will offer suitable space for our corporate needs while keeping our overall facility expenses in line. We appreciate the years of support from Emory University, Georgia Tech and the Georgia Research Alliance, all entities that were instrumental in contributing space and equipment while the Company was in its initial development phases. Our move is not only physical, but represents the continuing growth of GeoVax's leadership position in HIV vaccine technology."

GeoVax sharehold
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Formatech, Inc. to Donate Services to Formulate and Fill GeoVax Labs, Inc. HIV/AIDS Vaccine Under Its Fillanthropy(TM) Program
2. Encouraging HIV/AIDS Vaccine Trial Results Support GeoVax Labs, Inc. Strategy
3. GeoVax Labs Requests pre-IND Meeting With FDA
4. GeoVax to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
5. GeoVax Labs, Inc. Provides Clinical Studies Update
6. GeoVax Labs, Inc. Announces Resignation of Director
7. GeoVax Signs HIV/AIDS Vaccine Proposal With Health and Hospital System of Cook County, Illinois
8. GeoVax to Exhibit at the 2009 BIO International Convention
9. GeoVax Labs, Inc. Announces First Quarter Financial Results
10. GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results
11. GeoVax Update Provided at the BIO CEO & Investor Conference 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Tooth decay is an epidemic in American children ... disease. The World Health Organization says that worldwide, 60–90% ... cavities. What are the long-term effects of this transmissible infection? ... between the oral bacterial imbalance and serious systemic issues like ... it is also 100% preventable? Answer: there has been no ...
(Date:5/16/2013)... New Zealand (PRWEB) May 16, 2013 In ... was invited to speak to doctors in China about ... Australia and NZ, this was her first trip to lecture ... Dr. Hart visited Guangzhou and Fuzhou, home to 12 and ... in China is very high at this point in time. ...
(Date:5/16/2013)... , May 16, 2013  HealthSparq, a ... of the nation,s largest regional health plans, will ... Health Insurance Plans (AHIP) Institute 2013 conference on ... survey results showing how health insurance companies across ... the consumer and marketplace demands for increased healthcare ...
(Date:5/16/2013)... On average, developing a new drug ... dollars. Despite this investment, less than 10% of drugs ... your clinical trial design optimally structured to balance time, ... Dr. Frederic Sax, Global Head of the Center for ... data, information and technology in upfront clinical trial planning ...
Breaking Biology Technology:Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 3HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 2HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 3Optimizing Clinical Trials Outcomes through Computer Assisted Design, New Life Science Webinar Hosted by Xtalks 2
... supplier of financial technology solutions and subsidiary of Marshall ... in Virginia and Pennsylvania. , ,On Monday the company announced ... loan origination solutions headquartered in Wayne, Pa. GHR was acquired ... in the third quarter of 2005. , ,Metavante said in ...
... June 20 issue of The Scientist , named Madison, ... the city's research facilities and open community make it one ... and life sciences company. , ,Jim Leonhart, executive vice president ... said that the magazine, which was released during the BIO ...
... husband or wife, daughter or son, sister or brother? , ... confessional. I've just been thinking about the IT/business relationship. When ... work, it's funny how frequently the conversation turns to communication, ... ,"Oh great!" you're thinking. "Now you want me to get ...
Cached Biology Technology:The Scientist magazine names Madison "hotspot" for biotechnology 2The Scientist magazine names Madison "hotspot" for biotechnology 3Taking your work home 2Taking your work home 3
(Date:5/18/2013)... presented today at Digestive Disease Week (DDW) explores new ... impact of coffee on autoimmune disease and palliative care ... has been associated with reduced risk of fibrosis, a ... of java each month also correlate with lower risk ... Mayo Clinic, Rochester, MN, linked coffee consumption with reduced ...
(Date:5/17/2013)... of the South, but the night belongs to the amphibians. ... from the humidity and the sounds of wildlife. , ... toads and salamanders, is the center of amphibian biodiversity in ... auditorium for their symphonic choruses, the scientists of the U.S. ... front-row seats. , Amphibians, which rely on water ...
(Date:5/17/2013)... Why Tibetan antelope can live at elevations of ... research published in Nature Communications , investigators ... evidence that some genetic factors may be associated ... The data in this work will also provide ... biology of other ruminant species. , The Tibetan ...
Breaking Biology News(10 mins):Coffee consumption associated with reduced risk of autoimmune liver disease 2Front-row seats to climate change 2Front-row seats to climate change 3Front-row seats to climate change 4The genome sequence of Tibetan antelope sheds new light on high-altitude adaptation 2
... 22, 2011 Jerusalem, Israel The Israeli Chairmanship of ... and innovation, announced today in Jerusalem that since the ... 220 cooperative R&D projects have been approved and supported ... Assembled in Jerusalem for the fourth and final ...
... tattoo that delivers drugs to combat the debilitating and ... women in Haiti on HIV prevention; to a rugged, ... order to save babies, lives in Africa, Canadian innovators ... quest to make a difference in the developing world ...
... School of Medicine have found in a Phase II ... stabilized or improved cardiac function in people with severe ... therapy, called SERCA2a, experienced substantial clinical benefit and significantly ... this population. The data are published online in the ...
Cached Biology News:EUREKA invested over 300 million euros in industrial initiatives over the past year 2EUREKA invested over 300 million euros in industrial initiatives over the past year 3EUREKA invested over 300 million euros in industrial initiatives over the past year 4Grand Challenges Canada announces innovative rising stars in global health 2Grand Challenges Canada announces innovative rising stars in global health 3Grand Challenges Canada announces innovative rising stars in global health 4Mount Sinai researchers develop new gene therapy for heart failure 2
... griseolusthat inhibits protein synthesis. Acts by ... ribosomes. Reported to induce apoptosis in ... leukemia cells, Jurkat cells, ventricular myocytes, ... signals and immediate early gene induction. ...
5X StabilCoat Immunoassay Stabilizer is a 5X concentrate solution of StabilCoat Immunoassay Stabilizer. The shelf-life of 5X StabilCoat Immunoassay Stabilizer is 2 years when stored at 4C. Product ...
... IgM binds poorly to Protein A and, until ... for one- step IgM purification. Standard methods for ... they are not effective for removing all of ... Pierce has developed an ...
5X StabilCoat Immunoassay Stabilizer is a 5X concentrate solution of StabilCoat Immunoassay Stabilizer. The shelf-life of 5X StabilCoat Immunoassay Stabilizer is 2 years when stored at 4C. Product ...
Biology Products: